Pharmacological Treatment of Traumatic Brain Injury
Author:
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 15 (7) , 553-581
Abstract
Successful treatment strategies for patients with traumatic brain injury (TBI) remain elusive despite standardised clinical treatment guidelines, improved understanding of mechanisms of cellular...Keywords
This publication has 153 references indexed in Scilit:
- Reducing Calcium Overload in the Ischemic BrainNew England Journal of Medicine, 1999
- Cyclosporin A Attenuates Acute Mitochondrial Dysfunction Following Traumatic Brain InjuryExperimental Neurology, 1999
- Cyclosporin A Significantly Ameliorates Cortical Damage Following Experimental Traumatic Brain Injury in RodentsJournal of Neurotrauma, 1999
- Alterations in Ionized and Total Blood Magnesium After Experimental Traumatic Brain InjuryJournal of Neurochemistry, 1999
- Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in ratsJournal of Neurosurgery, 1999
- Rivastigmine, a Brain-Selective Acetylcholinesterase Inhibitor, Ameliorates Cognitive and Motor Deficits Induced by Closed-Head Injury in the MouseJournal of Neurotrauma, 1998
- EBIC-Guidelines for management of severe head injury in adultsActa Neurochirurgica, 1997
- Nimodipine in traumatic subarachnoid haemorrhage: A re-analysis of the HIT I and HIT II trialsActa Neurochirurgica, 1996
- Zinc Supplementation Is Associated with Improved Neurologic Recovery Rate and Visceral Protein Levels of Patients with Severe Closed Head InjuryJournal of Neurotrauma, 1996
- Neuroprotective Properties of the Uncompetitive NMDA Receptor Antagonist Remacemide HydrochlorideAnnals of the New York Academy of Sciences, 1995